Martine Kruijtbosch

136 Chap t e r 3. 3 REFERENCES 1. Fox ER, Sweet BV, Jensen V. Drug shortages: A complex health care crisis. Mayo Clin Proc 2014;89:361-373. 2. Tan YX, Moles RJ, Chaar BB. Medicine shortages in Australia: Causes, impact and management strategies in the community setting. Int J Clin Phar 2016;38:1133-1141. 3. Walker J, Chaar BB, Vera N, Alvish S, Pillai AS, Lim JS, et al. Medicine shortages in Fiji: A qualitative exploration of stakeholders’ views. PLoS One 2017;12:1-16. 4. Bochenek T, Abilova V, Alkan A, Asanin B, de Miguel Beriain I, Besovic Z, et al. Systemic measures and legislative and organizational frameworks aimed at preventing or mitigating drug shortages in 28 European and Western Asian countries. Front Pharmacol 2018;8:942. 5. Postma DJ, De Smet PAGM, Gispen-de Wied CC, Leufkens HGM, Mantel-Teeuwisse AK. Drug shortages from the perspectives of authorities and pharmacy practice in the Netherlands: An observational study. Front Pharmacol 2018;9:1243. 6. Said A, Goebel R, Ganso M, Zagermann-Muncke P, Schulz M. Drug shortages may compromise patient safety: Results of a survey of the reference pharmacies of the drug commission of German pharmacists. Health Policy 2018;122:1302-1309. 7. Javadi M, Ashrafi N, Salari P. Assessment of pharmacists experiences and attitudes toward professionalism and its challenges in pharmacy practice. Iran J Pharm Res 2018;17:168-177. 8. Cooper RJ, Bissell P, Wingfield J. Ethical decision-making, passivity and pharmacy . J Med Ethics 2008;34:441-445. 9. European patient organisations position on shortages medicinal products. Common position between patients, consumers, and healthcare professionals’ organisations involved in the activities of the European Medicines Agency on supply shortages of medicines. October 2013. http://download2.eurordis.org.s3.amazonaws.com/documents/pdf/common-position-supply- shortages-final-10-2013.pdf. Accessed 25 May 2021. 10. Kruijtbosch M, Floor-Schreudering A, van Leeuwen E, Göttgens-Jansen W, Bouvy ML. Moral reasoning perspectives of community pharmacists in situations of drug shortages. Res Soc Adm Pharm 2020. Available online 20 November 2020. 11. Rest J, Thoma SJ, Narvaez D, Bebeau MJ. Alchemy and beyond: Indexing the Defining Issues Test. J Educ Psychol 1997;89:498-507. 12. Thoma SJ, Rest JR. The relationship between moral decision making and patterns of consolidation and transition in moral judgment development. Dev Psychol 1999;35:323-334. 13. Jacobs S, Ashcroft D, Hassell K. Culture in community pharmacy organisations: What can we glean from the literature? J Health Organ Manag 2011;25:420-454. 14. Van de Pol J, Koster E, Hövels A, Bouvy ML. Balancing traditional activities and cognitive pharmaceutical services by community pharmacists: a work sampling study. Int J Clin Pharm 2019;41:872-879. 15. Elm DR, Kennedy EJ, Lawton L. Determinants of Moral Reasoning: Sex Role Orientation, Gender, and Academic Factors. Bus Soc 2001;40:241-265.

RkJQdWJsaXNoZXIy ODAyMDc0